Genus PLC
LSE:GNS

Watchlist Manager
Genus PLC Logo
Genus PLC
LSE:GNS
Watchlist
Price: 1 786 GBX 0.56% Market Closed
Market Cap: 1.2B GBX
Have any thoughts about
Genus PLC?
Write Note

Genus PLC
Total Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Genus PLC
Total Equity Peer Comparison

Comparables:
CNTA
EXAI
AUTL
BCYC
IMCR

Competitive Total Equity Analysis
Latest Figures & CAGR of Competitors

Company Total Equity CAGR 3Y CAGR 5Y CAGR 10Y
Genus PLC
LSE:GNS
Total Equity
ÂŁ548.2m
CAGR 3-Years
3%
CAGR 5-Years
3%
CAGR 10-Years
7%
Centessa Pharmaceuticals PLC
NASDAQ:CNTA
Total Equity
$236.2m
CAGR 3-Years
324%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Exscientia PLC
NASDAQ:EXAI
Total Equity
ÂŁ355.7m
CAGR 3-Years
64%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Autolus Therapeutics PLC
NASDAQ:AUTL
Total Equity
$111.5m
CAGR 3-Years
-19%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Bicycle Therapeutics PLC
NASDAQ:BCYC
Total Equity
$831m
CAGR 3-Years
69%
CAGR 5-Years
54%
CAGR 10-Years
N/A
Immunocore Holdings PLC
NASDAQ:IMCR
Total Equity
ÂŁ368.8m
CAGR 3-Years
88%
CAGR 5-Years
45%
CAGR 10-Years
N/A

See Also

What is Genus PLC's Total Equity?
Total Equity
548.2m GBP

Based on the financial report for Jun 30, 2024, Genus PLC's Total Equity amounts to 548.2m GBP.

What is Genus PLC's Total Equity growth rate?
Total Equity CAGR 10Y
7%

Over the last year, the Total Equity growth was -5%. The average annual Total Equity growth rates for Genus PLC have been 3% over the past three years , 3% over the past five years , and 7% over the past ten years .

Back to Top